According to guideline recommendations, individualized long-term measures must be adapted to the personal risk profile and disease activity. The overriding treatment goal is the best possible reduction of future fracture risk. To achieve this, meaningful sequential therapy is the most promising approach. This allows a sustainable long-lasting effectiveness to be achieved.